Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.71 USD | +1.35% | +1.49% | 0.00% |
Apr. 30 | Morgan Stanley Starts Contineum Therapeutics With Overweight Rating | MT |
Apr. 30 | Stifel Starts Contineum Therapeutics With Buy Rating, $29 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 395M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.17% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- CTNM Stock
- News Contineum Therapeutics, Inc.
- Stifel Starts Contineum Therapeutics With Buy Rating, $29 Price Target